AI Insights · Timothy · April 2024
Top 5 Medical Apps on iOS in Luxembourg: Q1 2024 Performance
Discover the performance trends of the top 5 medical apps on iOS in Luxembourg during Q1 2024, including weekly downloads, revenue, and active users.
In Q1 2024, the top 5 medical apps on iOS in Luxembourg demonstrated varied performance across weekly downloads, revenue, and active users. Below is a detailed analysis of each app's performance metrics.
AMBOSS Wissen für Mediziner from AMBOSS saw a fluctuating weekly revenue throughout the quarter. Starting at $89 in the first week of January, it peaked at approximately $325 in mid-March. Weekly downloads remained minimal, with a slight increase to 3 downloads mid-January and sporadic figures thereafter.
Dr. Pimple Popper by Skin PS Brands observed a steady revenue stream, starting at $98 in the first week of January and experiencing slight fluctuations, peaking at $166 in early March. However, it had no recorded downloads during the entire quarter.
VIDAL Mobile from VIDAL experienced significant revenue fluctuations. It started at $71 in the first week of January, peaking at $308 in the second week, and ended the quarter at $129. Weekly downloads showed minimal activity, with occasional spikes such as 4 downloads at the end of January.
Huckleberry: Baby & Child by Huckleberry Labs Inc. had an impressive revenue increase, starting at $7 and peaking at $314 in mid-March. Weekly downloads were sparse, with a few notable weeks such as 12 downloads in early March. Active user numbers saw a slight increase, starting at 41 and ending at 47 by the end of the quarter.
Pregnancy + | Tracker App from Philips Digital UK Limited had a relatively stable performance. Weekly revenue started at $114, fluctuating and peaking at $153 in late February. Downloads remained consistent, with weekly figures around 40-50. The app maintained a strong active user base, starting at 3.4K and ending at 3.3K.
These insights provide a snapshot of the top medical apps' performance on iOS in Luxembourg during Q1 2024. For more detailed data and further insights, visit Sensor Tower.